Funding for this research was provided by:
Received: 10 April 2020
Revised: 25 September 2020
Accepted: 25 October 2020
First Online: 16 November 2020
Compliance with ethical standards
: AE has received research grants from Jazz Pharmaceuticals and NewLink Genetics. AE is a global oncology advisory board member for Amgen and has served as an advisory board member for Genentech and Servier. AE and RGL are Co-Founders and Scientific Advisors for KinaRx, LLC. All other authors declare that they have no relevant competing interests.